Cargando…
MiR‐630 suppresses non‐small cell lung cancer by targeting vimentin
OBJECTIVE: This study aimed to clarify the function of miR‐630 on non‐small cell lung cancer (NSCLC) cells. METHODS: Quantitative real‐time PCR was utilized to detect the mRNA expression of miR‐630 and vimentin (VIM) in NSCLC tissues and cells. The protein expression of VIM, P53, Caspase‐3, Bcl‐2, B...
Autores principales: | Wang, Bin, Li, Jie, Li, Yulin, Liang, Tao, Chu, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459278/ https://www.ncbi.nlm.nih.gov/pubmed/35837990 http://dx.doi.org/10.1002/jcla.24536 |
Ejemplares similares
-
MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015) -
CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630
por: Zhang, Yan, et al.
Publicado: (2017) -
miR-630 functions as a tumor oncogene in renal cell carcinoma
por: Zhao, Jian-Jun, et al.
Publicado: (2016) -
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma
por: Chen, Wei-xun, et al.
Publicado: (2016) -
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
por: Simiene, Julija, et al.
Publicado: (2023)